News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|March 25, 2022

Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids

Author(s)Miranda Hester

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

ELEVIDYS demonstrates sustained functional benefit through 3 years in ambulatory Duchenne muscular dystrophy | Image Credit: © photoopus - stock.adobe.com.

ELEVIDYS demonstrates sustained functional benefit through 3 years in ambulatory Duchenne muscular dystrophy

ByMorgan Ebert, Managing Editor

January 28th 2026

FDA accepts centanafadine NDA for priority review for ADHD in children, adolescents

FDA accepts centanafadine NDA for priority review for ADHD in children, adolescents

ByMorgan Ebert, Managing Editor

January 27th 2026

Phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years and older | Image Credit: © aboutnuylove - stock.adobe.com.

Results from phase 3 trials support amlitelimab efficacy for atopic dermatitis in patients 12 years or older

ByMorgan Ebert, Managing Editor

January 23rd 2026

FDA clears first at-home test to detect RSV, flu, and COVID-19 in infants as young as 6 months

FDA clears first at-home test to detect RSV, influenza, and COVID-19 in infants as young as 6 months

ByMorgan Ebert, Managing Editor

January 23rd 2026

INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5

INTEGUMENT-PED trial shows consistent efficacy of roflumilast cream in children aged 2 to 5

ByVimal H. Prajapati, MD

January 20th 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Trending on Contemporary Pediatrics

Renée Shellhaas, MD, MS, highlights breathing issues in spina bifida

Hilary Brown, PhD, highlights maternal multimorbidity's link to neonatal morbidity and mortality

Henri Salo, MD, discusses how cardiovascular risk factors may impact cognitive function

AAP calls for system-level changes to improve children’s digital media environments

GLP-1 RA prescribing for adolescents with obesity remains low, with persistent disparities